Is Electromed, Inc. (ELMD) Overvalued?
We dive into why Electromed, Inc. (ELMD) could be considered overvalued on 2026-08-17, based on AAII’s Value Score and Grade.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Commentary & Analysis
Why Electromed, Inc.’s (ELMD) Stock Is Up 5.02%
As of Thursday, July 09, Electromed, Inc.’s ELMD share price has surged by 5.02%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Electromed, Inc.’s (ELMD) Stock Is Up 5.37%
As of Friday, June 26, Electromed, Inc.’s ELMD share price has surged by 5.37%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Electromed, Inc.’s (ELMD) Stock Is Up 5.02%
As of Monday, May 18, Electromed, Inc.’s ELMD share price has surged by 5.02%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Electromed, Inc.’s (ELMD) Stock Is Up 7.20%
As of Thursday, May 14, Electromed, Inc.’s ELMD share price has surged by 7.20%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $326.6 | $422.9 | 32% |
|
| Shares Out (Mil) | 8.6 | 41.4 | 19% |
|
| Institutional Ownership | 77.6% | 83.6% | 47% |
|
| Float (Mil) | 6.8 | 34.9 | 15% |
|
| Beta | 0.39 | 0.88 | 22% |
|
| Avg Daily Volume (000s) | 64 | 409 | 30% |
|
| Price Change (52-week) |
101.2% | 66.3% | 90% |
|
| Growth | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 14.5% | 11.9% | 72% |
|
| Net Income (5yr) | 12.3% | (5.9%) | 59% |
|
| EPS (5yr) | 12.6% | 10.4% | 51 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.9%) | (16.2%) | 39% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $72 | $123 | 23% |
|
| Net Income (TTM) (Mil) | $10 | ($9) | 46% |
|
| EPS (TTM) | $1.220 | ($0.400) | 63% |
|
| Operating Cash Flow (TTM) (Mil) | $11 | ($3) | 38% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $1 | 47% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $22 | 10% |
|
| Enterprise Value (Q1) (Mil) | $303 | $418 | 30% |
|
| Valuation | ELMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.64 | 3.13 | 84% |
|
| P/E | 33.7 | 28.1 | 73% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 2.7 | 1.7 | 75% |
|
| Ratios | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 78.4% | 58.7% | 88% |
|
| Net Margin | 14.1% | (6.9%) | 71% |
|
| ROA | 18.1% | (12.3%) | 95% |
|
| ROE | 21.7% | (12.3%) | 81% |
|
| Liabilities to Assets | 17.3% | 46.0% | 11% |
|
| F-Score | 7 | 4 | 82% |
|
Passing Stock Screens
As of 8/21/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Return on Equity Screen
Factors: Quality, Growth
A screen that identifies stocks with above average earnings and sales growth that have consistently outperformed their peers measured by ROE.
| Performance Since Inception: | 13.1% |
| +/- S&P 500: | +5.6 |
